Atlas Trials

Study Assessing Safety and Immunogenicity of IC43 Vaccination Against Pseudomonas Aeruginosa in Healthy Volunteers

Clinical trial NCT00778388 · COMPLETED

Trial details

NCT number
NCT00778388
Sponsor
Valneva Austria GmbH
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2008-09-01
Primary completion
2009-09-01
Enrollment
157

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.